Clinical factors associated with complete restoration of left ventricular systolic function in chronic heart failure patients treated with beta-blockers

Preserved Left Ventricular, Systolic Function in Clinical Congestive Heart Failure

Sleep quality and associated factors among patients with chronic heart failure in Iran

  Background: Sleep disorders are common among patients with chronic heart failure (HF), and it can have a significant effect on patients’ daily activities as well as their health. The purpose of this study was to assess sleep quality and its predictors in Iranian patients with chronic HF.   Methods : This cross-sectional study was conducted on a sample of 200 patients with HF in two hospitals ...

Effects of exercise training in patients with chronic heart failure and advanced left ventricular systolic dysfunction receiving β-blockers.

BACKGROUND It remains unclear whether patients with chronic heart failure (CHF) and advanced left ventricular (LV) dysfunction on β-blocker therapy benefit from exercise training (ET). METHODS AND RESULTS We studied 45 CHF patients with advanced LV dysfunction [ejection fraction (LVEF) < 25%] and impaired exercise tolerance [normalized peak oxygen uptake (PVO₂) < 70%] receiving a β-blocker: 3...

Self-care behaviors in patients with systolic heart failure

Background and Purpose: To improve life quality, and lower mortality and rehospitalization for heart failure patients, awareness and adherence to self-care behaviors are essential. This study aims to determine the adherence level to self-care behaviors in the patients with systolic heart failure hospitalized in Alborz hospital in Karaj andShahriar hospital, and it was conducted in 2013. Methods...

Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure.

The effect of torasemide and furosemide therapy was compared in 50 patients who had chronic heart failure and symptoms [NYHA class II-III] despite long-term therapy with both low-dose furosemide and angiotensin-converting enzyme inhibitors. In this randomized 6-month, open-label trial, baseline and follow-up echocardiograms and neurohumoral assays were obtained in 25 group F patients (continued...